Private Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Private Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Buy	20,586 +34	+0.2%	+$1.98K	0.04%	197
2025 Q4	$1.11M	Hold	20,552	–	–	0.03%	194
2025 Q3	$927K	Hold	20,552	–	–	0.03%	193
2025 Q2	$951K	Buy	+20,552	New	+$1.01M	0.03%	186

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Management Group's BMY Position: Q1 2026 in Review

Private Management Group increased its Bristol-Myers Squibb (BMY) stake by 0.17% in Q1 2026, buying an estimated $1.98K and bringing the position to 20,586 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #197.

Private Management Group first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Private Management Group held 20,586 shares of Bristol-Myers Squibb worth $1.25M as of Q1 2026.
Private Management Group bought 34 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.98K.
Bristol-Myers Squibb made up 0.04% of Private Management Group's portfolio in Q1 2026, its #197 holding.
Private Management Group first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Private Management Group's 13F filing for Q1 2026, filed 8 May 2026.